Prevention trial for HIV
Official title Alcohol Research in HIV: Relapse Prevention
ClinicalTrials.gov ID: NCT05163301
What this study is testing
- What it's testing
- The study wants to find out if this two‑session relapse‑prevention program is effective and practical for people with HIV and alcohol use problems.
- Who it's for
- Adults living with HIV who also have an alcohol use disorder.
- What's involved
- Participants will take part in two sessions that combine computer‑based tools with personal counseling to help prevent drinking relapse.
- Time commitment
- The trial involves two study sessions over a brief period, with any required follow‑up visits.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Confirmed diagnosis of HIV
- Aged 18 years or older
- lifetime alcohol use disorder
- patient reported outcomes (PRO) assessment collected by the Center for AIDS Research (CFAR) Network of Clinical Systems as part of usual clinical...
- current PRO showing alcohol abstinence or alcohol use at \<11/22 drinks per week for women/men.
You likely can't join if
- Acutely suicidal, homicidal, psychotic or otherwise unable to provide informed consent
- Non-English speaking because interventions are currently available in English only
The study team makes the final eligibility decision.
Where it is enrolling
- Baltimore, Maryland, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Baltimore, Maryland, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.